CRISPR/Cas9 genome editing techniques have the potential to treat previously untreatable inherited genetic disorders of vision by correcting mutations that cause these afflictions. Using a prime editor, Qin et al. (2023. J. Exp. Med.https://doi.org/10.1084/jem.20220776) restored visual functions in a mouse model (rd10) of retinitis pigmentosa.
J Exp Med. 2023 May 1;220(5):e20230146. doi: 10.1084/jem.20230146. Epub 2023 Mar 17.
ABSTRACT
CRISPR/Cas9 genome editing techniques have the potential to treat previously untreatable inherited genetic disorders of vision by correcting mutations that cause these afflictions. Using a prime editor, Qin et al. (2023. J. Exp. Med.https://doi.org/10.1084/jem.20220776) restored visual functions in a mouse model (rd10) of retinitis pigmentosa.
PMID:36930175 | DOI:10.1084/jem.20230146
English
Arabic
Russian
French
Chinese (Simplified)
Japanese
Portuguese
Spanish